# E-DRUG: Help wanted - Russian drug **URL:** \ **Category:** e-drug\ **Created:** [October 11, 1997, 12:39pm UTC](https://talk.edrugplus.org/t/e-drug-help-wanted-russian-drug/1520 "1997-10-11T12:39:15Z")\ **Posts on this page:** 1\ **Page:** 1
**Author:** ![cima](https://avatars.discourse-cdn.com/v4/letter/c/e8c25b/32.png) [@cima](https://talk.edrugplus.org/u/cima)\ **Post date:** [October 11, 1997, 12:39pm UTC](https://talk.edrugplus.org/t/e-drug-help-wanted-russian-drug/1520/1 "1997-10-11T12:39:15Z")
E-DRUG: Help wanted - Russian drug ----------------------------------          Dear colleagues:                                         We have received a question about a Russian medicine called MUCALTHINI TABULETTAE 0.05. We were unable to find any information about this drug in Martindale, IDIS, MEDLINE, USP-DI, and Merck Index. Can somebody help us? Thanks for your attention.      Albert Gomis Centro de informacion del medicamento de Alicante. (Drug information service of Alicante) C. jorge juan 8. 03002 - Alicante (Spain) fax: (96) 520 36 52 tphn: (96) 520 95 49 e-mail: cima@recol.es Note from the moderator: ------------------------ As mentioned in an earlier posting, the United States Pharmacopeia (USP) is preparing a directory of drug information centers (DIC) around the world and a manual on How to set up and run a DIC. One of the advantages of a worldwide directory of DICs will be to help in getting quick responses of requests like the one above by submitting enquiry directly to a DIC located in a country. If you have any ideas please email to Mustafa Farouq at USP (mf@usp.org) who is working on this project. Meanwhile, some of you who are associated with DICs may have received/will receive a questionnaire from Mustafa. Please return the completed questionnaire as soon as possible. Thanks. Syed Rizwanuddin Ahmad Email: srahmad@essential.org -- Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'. Mail administrative requests to `majordomo@usa.healthnet.org'. For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.